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Polygenic Autoimmune Traits: Lyn, CD22, and SHP-1
Are Limiting Elements of a Biochemical Pathway
Regulating BCR Signaling and Selection
disorders are largely unknown, but the continuous varia-
tion in genetic risk from individual to individual repre-
sents a complex quantitative trait that might reflect
quantitative variation in the protein components of bio-
chemical pathways. Since quantitative traits are subject
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The src family protein tyrosine kinase Lyn is abun-A B lymphocyte hyperactivity syndrome resembling
dantly expressed in B cells and is thought to be a keysystemic lupus erythematosus characterizes mice
initiator of B cell antigen receptor (BCR) signaling (Bolenlacking the src-family kinase Lyn. Lyn is not required
and Brugge, 1997; DeFranco, 1997; Kurosaki, 1997). Ato initiate B cell antigen receptor (BCR) signaling but
small amount of cellular Lyn is physically associatedis an essential inhibitory component. lyn2/2 B cells have
with the BCR and is activated upon BCR stimulationa delayed but increased calcium flux and exaggerated
(Burkhardt et al., 1991; Yamanashi et al., 1991; Campbellnegative selection responses in the presence of anti-
and Sefton, 1992). Chicken B lymphoma cells lackinggen and spontaneous hyperactivity in the absence of
Lyn have delayed and diminished BCR-induced intracel-antigen. As in invertebrates, genetic effects of loci
lular calcium release, indicating that Lyn has a role inwith only one functional allele can be used to analyze
this process (Kurosaki et al., 1994; Takata et al., 1994).signaling networks in mice, demonstrating that nega-
Mice homozygous for a disruption of the lyn locustive regulation of the BCR is a complex quantitative
(lyn2/2), however, display normal immature B cell devel-trait in which Lyn, the coreceptor CD22, and the tyro-
opment but have decreased numbers of mature periph-sine phosphatase SHP-1 are each limiting elements.
eral B cells, greatly elevated serum immunoglobulin (Ig)The biochemical basis of this complex trait involves
M and IgA, and production of autoantibodies that causea pathway requiring Lyn to phosphorylate CD22 and
autoimmune glomerulonephritis reminiscent of systemicrecruit SHP-1 to the CD22/BCR complex.
lupus erythematosus (Hibbs et al., 1995; Nishizumi et
al., 1995; Chan et al., 1997). Surprisingly, antibody re-Introduction
sponses to antigenic challenge are relatively normal in
lyn2/2 mice, and Lyn-deficient splenicB cells make exag-Susceptibility to complex diseases, such as autoim-
gerated proliferative and extracellular signal-relatedmune diabetes or systemic lupus erythematosus, is de-
protein kinase responses after BCR clustering and rela-termined by the combined effects of alleles at multiple
tively normal but delayed patterns of antiimmunoglobu-genetic loci (Drake et al., 1995; Theofilopoulos, 1995b;
lin-induced protein phosphorylation (Wang et al., 1996;Vyse and Todd, 1996; Morel et al., 1997). The nature
Chan et al., 1997). These abnormalities contrast sharplyand biochemical effects of allelic variants for polygenic
with the phenotype of CD45-deficient mice (Cyster et
al., 1996) or of Lyn-deficient chicken B lymphoma cells,
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Figure 1. Development of Lyn-Deficient B Cells in the Presence and Absence of Self-Antigen
(A) Stages of B cell differentiation and cell surface markers used to distinguish them.
(B) Numbers of HEL-binding B cells and anti-HEL IgMa-secreting plasma cells in lymphoid organs of radiation chimeras constructed in
nontransgenic and ML5 HEL-transgenic mice (denoted by self-antigen ªnoneº and ªHELº respectively) reconstituted with lyn1/1, lyn1/2, or
lyn2/2 IgHEL-transgenic bone marrow. Bone marrow numbers represent the total immature B cells in two femurs and two tibias. Data from two
separate experiments are combined and mice were analyzed in cohorts between 51 and 117 days after chimera construction. Dots, the
number from separate chimeric animals; bars, geometric means. Enzyme-linked immunosorbent assay analysis of serum from these chimeras
showed that secreted anti-HEL IgMa was present at geometric means (standard errors) of 20.93 mg/ml (6.81), 19.94 mg/ml (11.65), and 376.47
mg/ml (88.08) in lyn1/1, lyn1/2, and lyn2/2 mice without sHEL, respectively, and less than 0.4 mg/ml in mice of each genotype expressing sHEL.
pathway that regulates B cell signaling through the phos- and light chain transgenes encoding IgMa and IgDa spe-
phorylation of CD22 and recruitment of the Src homol- cific for the well-defined protein antigen HEL (Goodnow
ogy domain (SH)-1±containing tyrosine phosphatase et al., 1988). The resulting lyn2/2 IgHEL-transgenic mice
SHP-1. Each of the elements of this pathway is present were of normal appearance, bred normally, and their
in limiting amounts, such that heterozygous mutant al- survival up to200 days of age was not markedlydifferent
leles of lyn, CD22, and SHP-1 that lower the functional from lyn1/1 IgHEL-transgenic littermates. The absence of
gene dose by half interact to create a complex quantita- mortality associated with glomerulonephritis implies
tive trait of B cell hyperreactivity. These results identify that the presence of the IgHEL transgene may have a
a pathway that tunes lymphocyte responsiveness and protective effect against the development of the autoim-
susceptibility to autoimmunity and demonstrate that the mune disease, which might coincide with the restricted
genetic approaches to analyzing signaling networks pi- repertoire of the B cells.
oneered in invertebrates (Simon et al., 1991; Yoon et al., To examine the effect of self-antigen upon the devel-
1995; Verheyen et al., 1996) can also be used in mice. opment of the Lyn-deficient B cells, lyn1/1, lyn1/2, and
lyn2/2 IgHEL-transgenic B cells were tracked during matu-
ration in bone marrow chimeric mice that express solu-Results
ble HEL (sHEL) as a circulating self-antigen in a form
and amount sufficient to trigger anergy but not deletionDevelopment of Lyn-Deficient B Cells
(Figure 1). In control chimeras that lacked HEL antigen,in the Presence and Absence
there was a 20-fold increase in the number of plasmaof Self-Antigen
cells secreting anti-HEL IgM in the spleen of mice recon-To study how Lyn deficiency affects B cell reactivity and
stituted with lyn2/2 bone marrow, compared to lyn1/1selection to antigen, mice heterozygous or homozygous
bone marrow (Figure 1B, panel 4), and an equivalentfor a targeted disruption of the lyn gene (lyn1/2 and lyn2/2)
increase in anti-HEL IgM antibodies was present in the(Hibbs et al., 1995) were crossed with IgHEL (hen egg ly-
sozyme)-transgenic mice carrying immunoglobulin heavy serum (Figure 1). Antigen-independent hypersecretion
Lyn/CD22/SHP-1 Pathway in B Cell Hyperactivity
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Figure 2. Expression of Different Cell Surface Molecules on Lyn-Deficient B Cells in the Presence and Absence of Self-Antigen
(A-E) Overlaid histograms showing cell surface staining for complement receptor CD21, CD22, IgD, IgM, or MHC class II on lyn1/1 IgHEL B cells
and lyn2/2 IgHEL B cells in chimeric mice with no HEL antigen or expressing circulating sHEL (HEL). Cells with different levels of CD21 or IgD
expression, corresponding to progressive stages in development, are indicated. Equivalent results were found in a minimum of six chimeric
mice from two separate sets of chimeras. There is no histogram for MHC class II expression on lyn2/2 IgHEL B cells in the presence of sHEL
because of the negative selection of all splenic B cells in this mouse.
of IgM occurred at a comparable level in unmanipulated 1995) and mirrors the normal tolerance response to
forms of the antigen that cluster BCRs more avidly, suchlyn2/2 IgHEL-transgenic mice (data not shown). By con-
trast, in the continuous presence of circulating sHEL as membrane HEL (Hartley et al., 1991; Hartley et al.,
1993) or a soluble dimeric HEL protein (S. Akkaraju etantigen (Figure 1), plasma cell formation and anti-HEL
antibody secretion (Figure 1B) were completely sup- al., unpublished data).
In mice lacking HEL, mature lyn2/2 B cells (CD21med,pressed regardless of the lyn genotype. Thus, active
induction of antigen-specific B cell tolerance was intact CD22high, IgDhigh) (Figure 1A) developed but were present
in smaller numbers in the spleen and lymph node (Figurein Lyn-deficient B cells.
Analysis of the steps in B cell development preceding 1B, panels 2 and 3), and few mature cells recirculated
back to the bone marrow (Figure 2A, open histogram).plasma cells (Figure 1B, panels 1±3) indicated that nega-
tive selection to self-antigen was in fact exaggerated Mature CD22high IgDhigh lyn2/2 B cells expressed 4- to 5-fold
lower surface IgM, 2-fold lower levels of CD21, and twiceby Lyn deficiency. In sHEL-expressing mice, few mature
lyn2/2 B cellswere present in thespleen and lymph nodes as much major histocompatibility complex class II (MHC
class II) as on mature lyn1/1 B cells in the absencedespite normal numbers of immature B cells in the bone
marrow. Interestingly, lyn1/2 B cells showed an interme- of antigen (Figures 2A±2E). These antigen-independent
changes in cell number and phenotype parallel thediate levelof deletion in thepresence of HEL. The lyn2/2 B
cells in the bone marrow and spleen of sHEL-expressing changes in SHP-1±deficient IgHEL B cells in the absence
of antigen (Cyster and Goodnow, 1995) and mirror themice were primarily immature B cells (CD21neg/low, CD22low,
IgDlow) (Figures2A±2C, unshaded histograms), indicating effects of B cell anergy normally brought about in lyn1/1
cells by chronic binding of sHEL antigen (Figures 1 andthat sHEL inhibited or aborted maturation of lyn2/2 cells
rather than inducing anergy as occurred in the lyn1/1 B 2, shaded lower panels). It is possible that the IgMlow
class IIhigh phenotype of mature lyn2/2 B cells reflectscells. The negative selection response of lyn2/2 B cells
to sHEL thus resembles the exaggerated response of selection of rare variant cells from the immature B cell
pool, rather than an effect of exaggerated signaling onSHP-1±deficient IgHEL B cells (Cyster and Goodnow,
Immunity
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Figure 3. Exaggerated Intracellular Calcium Response to Antigen or Anti-Receptor Antibody in Lyn-Deficient B Cells
Flow cytometry of indo-1 loaded cells was used to monitor intracellular calcium levels as a function of time after stimulation in immature bone
marrow B cells or mature splenic B cells expressing lyn (1/1) or lacking lyn (2/2). Arrows, time of addition of HEL antigen or polyclonal goat
anti-mouse IgM. All measurements were gated on B2201 cells. (A-B) immature B cells were selectively gated as B220low. Note that the peak
calcium elevation occurs later in lyn2/2 cells than in lyn1/1 cells, but calcium reaches much higher concentrations and is elevated for longer
periods of time. Equivalent results were obtained from four separate experiments.
all of the cells. Selection seems unlikely because cells cells from the bone marrow as well as mature cells from
with this phenotype are not detected in the immature the spleen were examined in case compensatory pro-
pool, and the small numbers of mature lyn2/2 B cells and cesses in mature cells such as IgM down-regulation
their apparent poor survival in the periphery would seem might have obscured signaling differences. In both de-
to provide little scope for selection. velopmental subsets, acute exposure to sHEL or anti-
Unlike nontransgenic lyn2/2 mice, no peritoneal B1 IgM induced a higher peak intracellular calcium concen-
lineage cells were detected in lyn2/2 IgHEL-transgenic tration and a more sustained rise of calcium in lyn2/2
mice (data not shown), indicating that the HEL-specific cells than in lyn1/1 controls (Figures 3A±3D). The effects
BCR remains nonpermissive to B1 cell formation in the of Lyn deficiency were evident at receptor-saturating
absence of Lyn. This result contrasts with SHP-1 defi- concentrations of HEL and at lower concentrations and
ciency, which allows peritoneal B1 cells expressing the were B cell autonomous, as indicated by analysis of
HEL-specific BCR to accumulate (Cyster and Goodnow, calcium responses in cells from mixed chimeric animals
1995) and indicates that IgM hypersecretion due to Lyn (data not shown). In addition, lyn2/2 B cells showed a
deficiency can be dissociated from B1 cell accumulation. consistent delay in the initial phase of the calcium re-
Construction of mixed chimeras with lyn2/2 and lyn1/1 sponse (Figures 3A±3D). These results imply that Lyn
bone marrow,using methods described previously (Cys- plays a role in the initiation of calcium mobilization as
ter and Goodnow, 1995), confirmed that the exagger- well as in its inhibition.
ated negative selection in the presence of sHEL antigen
and the developmental changes and antibody hyperse-
Genetic Interaction between Lyn and SHP-1cretion in the absence of antigen were due to Lyn defi-
The exaggerated BCR signaling and selection in lyn2/2ciency in the B cells themselves and not secondary to
IgHEL B cells described above represents an almost exactdisregulation of macrophages or other cell types in Lyn-
phenocopy of the changes brought about in IgHEL B cellsdeficient mice (data not shown).
by the homozygous loss of function mutation in the
SHP-1 tyrosine phosphatase motheaten viable (mev)Evidence for Exaggerated BCR Signaling
(Cyster and Goodnow, 1995). This similarity raised thein Lyn-Deficient Cells
question of whether the two proteins could be operatingThe exaggerated negative selection to self-antigen, to-
in a single pathway. To address this possibility, we em-gether with the spontaneous hypersecretion of anti-
ployed an approach that has been very useful for analyz-body, down-regulation of IgM, and elevated MHC class
ing signaling networks in Drosophila melanogaster andII on mature cells in the absence of antigen suggested
Caenorhabditis elegans (Simon et al., 1991; Yoon et al.,that the BCRs on lyn2/2 cells might be hyperactive. To
1995; Verheyen et al., 1996) by looking for a genetictest for the presence of exaggerated BCR signaling in
interaction between heterozygous mutants of Lyn andLyn-deficient mice, indo-1±loaded B cells were stimu-
SHP-1 where the dosage of functional genes was halved.lated with sHEL or anti-IgM and the changes in intracel-
lular calcium measured by flow cytometry. Immature B First, we observed that B cells in heterozygous mice
Lyn/CD22/SHP-1 Pathway in B Cell Hyperactivity
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Figure 4. Genetic Interaction between Het-
erozygous Alleles of lyn and mev Affects the
Density of IgM on the B Cell Surface
A) Overlaid histograms showing IgMa expres-
sion on mature (IgDa bright) IgHEL spleen B
cells of the indicated genotypes: WT (shaded)
versus lyn1/2mev1/1, lyn1/1mev/1, lyn1/2mev/1
(unshaded, thick lines). Results are represen-
tative of more than ten separate experiments.
(B) Median IgMa expression on mature IgDa
bright IgHEL B cells in the blood of mice with
the indicated genotypes. Dots, values from
individual animals from a single experiment;
bars,means for each genotype. Animals were
bled and samples stained for IgMa, B220, and
IgDa and analyzed by three-color FACS analy-
sis, before gating on IgDa bright cells (upper
25th percentile of IgDa). Two-way analysis of
variance (ANOVA) showed that IgM expres-
sion was very significantly affected by heterozygosity at lyn (F 5 254.43, 1 degree of freedom [df], p , 0.0001) or mev locus (F 5 221.229, 1
df, p , 0.0001) as well as by interaction between the two (F 5 16.887, 1 df, p 5 0.0002).
with a single functional lyn or SHP-1 allele (lyn1/2 or also have spontaneous down-regulation of IgM and ex-
aggerated calcium responses to BCR clustering (O'Keefemev/1) exhibited a degree of spontaneous IgM down-
et al., 1996; Otipoby et al., 1996; Sato et al., 1996;regulation that was intermediate between wild-type (WT)
Nitschke et al., 1997). This raises the possibility thatand lyn2/2 or mev/mev cells (Figure 4). This implied that
Lyn-induced phosphorylation of CD22 governs the re-a partial reduction in the function of either protein was
cruitment of SHP-1 to BCR-associated CD22. To testdetected within the B cells and resulted in a compensa-
this hypothesis, lyn2/2 and lyn1/1 IgHEL B cells were stimu-tory adjustment of surface IgM density. By intercrossing
lated with HEL in vitro and cell lysates examined byheterozygotes for the mev mutation and the lyn allele,
immunoprecipitation and Western blotting (Figure 5A).double heterozygous IgHEL mice with partial deficiency
In lyn1/1 B cells, antigen or anti-IgM induced a markedin both proteinswere produced. Simultaneous heterozy-
increase in tyrosine phosphorylation of CD22 and in-gosity at both lyn and mev loci caused B cells to adjust
creased binding of SHP-1 to CD22 (Figure 5A, i). Bytheir surface IgM density to a lower level than heterozy-
contrast, little increase in CD22 tyrosine phosphoryla-gosity at either locus alone (Figures 4A and 4B), indicat-
tion or SHP-1 binding to CD22 was induced by theseing a genetic interaction (ANOVA, p 5 0.0002).
stimuli in lyn2/2 cells. Antigen-induced phosphorylationApart from the spontaneous antigen-independent ad-
of CD79a/b and Syk was only modestly reduced in lyn2/2justment of IgM surface density, B cells from the single
B cells (Figure 5A, ii-iii), in agreement with other recentand compound heterozygotes appeared to tolerate par-
findings (Chan et al., 1997). Within the sensitivity of thesetial deficiency of Lyn and SHP-1 and were phenotypi-
biochemical assays, no difference could be detectedcally similar to WT cells. There was no reduction in num-
between lyn1/2 and lyn1/1 IgHEL B cells (data not shown).bers of mature B cells nor increased MHC class II in the
A basal level of CD22 phosphorylation and SHP-1absence of antigen and no hypersecretion of antibody
association with CD22 exists in unstimulated IgHEL B cells(data not shown). The antigen-induced calcium re-
in the absence of antigen (Figures 5A and 5B), as doessponse was similar to WT in the single and double het-
a basal phosphorylation of CD79a/b and Syk (Figure 5Aerozygotes, with the exception of a subtle increase of
and data not shown). lyn2/2 B cells retained normal basalrate and amplitude in mev/1 B cells.
phosphorylation of CD79a/b and Syk, but basal phos-
phorylation of CD22 and SHP-1 association was mark-
Lyn Is Required for Constitutive and Antigen-Induced edly reduced relative to lyn1/1 cells (Figure 5B).
Phosphorylation of CD22 and Recruitment of SHP-1
The genetic interaction between alleles encoding Lyn Genetic Interaction between Lyn, SHP-1, and CD22
and SHP-1 indicates that these proteins regulate the To test the functional significance of the biochemical
BCR through the same or parallel biochemical path- pathway involving Lyn, CD22, and SHP-1 in the regula-
ways. A possible link between Lyn and SHP-1 is the tion of the BCR, we asked whether partial deficiency in
coreceptor CD22, because SHP-1 is recruited to phos- CD22 could exaggerate the effects of partial Lyn and
phorylated tyrosine-based inhibition motifs (ITIMs) on SHP-1 deficiencies. Mice heterozygous for a targeted
CD22 after BCR clustering (Campbell and Klinman, deletion of CD22 (cd221/2) (Otipoby et al., 1996) were
1995; Doody et al., 1995; Law et al., 1996; reviewed by mated with mev/1 and lyn1/2 IgHEL-transgenic mice to
Cyster and Goodnow, 1997) and has been reported to generate sibships with fully WT or heterozygous mutant
be immunoprecipitated in a complex with both CD22 alleles at each of the three loci. Several animals from
and Lyn (Tuscano et al., 1996). Moreover, 0.2%±2% of each of the eight resulting genotypes were examined,
surface IgM receptor is constitutively associated with and radiation chimeras were established using one set
CD22, (Leprince et al., 1993; Peaker and Neuberger, of bone marrows to extend these observations and
study negative selection to self-antigen.1993) and B cells from CD22-deficient (cd222/2) mice
Immunity
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Figure 5. Lyn Is Required for Basal and Anti-
gen-Induced Phosphorylation of CD22 and
Recruitment of SHP-1
(A.i±iii) Western blots showing results of serial
immunoprecipitation of CD22, CD79b, and
Syk from lyn2/2 and lyn1/1 IgHEL spleen B cells.
Cells were stimulated with media alone
(time 5 0) or HEL (1 mg/ml) for periods of
30 s to 5 min. Panels show induced tyrosine
phosphorylation by probing the immunopre-
cipitates for anti-phosphotyrosine, relative to
total immunoprecipitated protein measured
by reprobing the same blot with antisera to
CD22, SHP1, CD79b, or Syk. (i) The level of
SHP-1 association with phosphorylated CD22
is demonstrated by probing the CD22 immu-
noprecipitates with an anti-SHP-1 antibody.
Results are representative of four experi-
ments using HEL as stimulant and four exper-
iments using anti-IgM as stimulant.
(B) Western blot of anti-CD22 immunoprecip-
itates from unstimulated IgHEL spleen B cells
of the indicated genotypes. Each lane repre-
sents splenic cells from a separate mouse.
Levels of CD22 tyrosine phosphorylation,
CD22 loading, and SHP-1 association with
CD22 are shown. The size difference between
phosphorylated andunphosphorylated forms
of CD22 in B cells from one of the lyn2/2mev/1
mice (lane 11) is of unknown significance.
Mature B cells in cd221/2 IgHEL mice expressed half of The variation in IgM receptor density contrasted with
the expression of developmental abnormalities that var-the normal cellsurface density of CD22 (data not shown).
In the absence of antigen, mature B cells from cd221/2 ied less continuously as a function of gene dosage, and
were presumably triggered by more discrete signalingmice adjusted their IgM receptors to a lower cell surface
density (Figure 6) but exhibited no other functional ab- thresholds. These more qualitative B cell phenotypes
became most evident in the cd221/2lyn1/2mev/1 triplenormality. When the partial deficiency of CD22 was com-
bined with partial deficiency for Lyn or SHP-1, the B heterozygotes. In the absence of self-antigen, partial
deficiency inall of the three proteins caused nodecreasecells further adjusted cell surface IgM to lower levels
that varied with the combination of alleles inherited. This in the number of mature B cells, but the cells expressed
lower levels of CD21 (Figure 7A) and increased MHCeffect was most extreme in the compound cd221/2
lyn1/2mev/1 triple heterozygote, which expressed 15% class II (Figure 7B), which in 3 of 5 mice was comparable
to the phenotype of lyn2/2 or mev/mev B cells in theof WT receptor levels (Figures 6A and 6B). Spontaneous
adjustment of surface receptor density was thus a con- absence of antigen (Figure 2 and Cyster and Goodnow,
1995). A greater than 15-fold increase in serum concen-tinuous, quantitative trait upon which single alleles at
three loci had a partial and additive effect. Each of the tration of HEL-binding IgM was present in 2 of 4 triple
heterozyogous mice, but not in any single or doublethree proteins was limiting based on theeffects of reduc-
ing gene dosage to a single functional allele, in the order heterozygous animals (data not shown). In the presence
of sHEL, negative selection was exaggerated in a cumu-mev.lyn.cd22, and there was locus heterogeneity be-
cause different combinations of alleles generated similar lative manner, as indicated by the decrease in number
of splenic B cells in both cd221/2lyn1/2mev/1 triple andlevels of modulation, e.g., lyn1/2cd221/2 heterozygote
having the same effect as mev/1 heterozygosity (Figure 6). cd221/2lyn1/2 and cd221/2mev/1 double heterozygotes
Lyn/CD22/SHP-1 Pathway in B Cell Hyperactivity
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Figure 6. Genetic Interaction between lyn,
mev, and cd22 Loci Defines a Quantitative
Trait
(A-B) Median IgMa levels on IgDa bright IgHEL B
cells (gated on the upper 25% of IgDa-positive
cells) from spleen and mesenteric lymph
node. At least two separate mice were ana-
lyzed for each genotype. Further data was
generated by analyzing radiation chimeras
that had been reconstituted with bone mar-
row of the different genotypes, and mice of
different genotypes were analyzed simulta-
neously. Chimeras were examined at 9±10
weeks after reconstitution and other mice at
6±8 weeks of age. Dots, individual mice; bars,
arithmetic means.
(Figure 7C). Negative selection was most exaggerated developmental arrest and deletion, proliferation, and
plasma cell differentiation.in cd221/2lyn1/2mev/1 triple heterozygous B cells be-
cause thespleen and bone marrow B cells that remained All three known elements of the regulatory pathway
are limiting, since the presence of a single functionalwere arrested at the CD21low immature stage (Figure
7D) and very few reached the lymph nodes (Figure 7D), copy of lyn, cd22, or mev caused compensatory adjust-
ment of surface IgM receptor density. Combinations ofsimilar to the lyn2/2 mice (Figure 1B).
these partial deficiencies had cumulative effects on IgM
receptor density and had threshold effects on other re-Discussion
sponses to BCR signaling, such as class II induction
and negative selection. The sensitivity to gene dosageThe above results establish that Lyn kinase is not re-
and genetic interactions among the members of thequired to initiate BCR signal transduction in B lympho-
pathway provide a clear example of polygenic controlcytes, but it is one of three molecules that are essential
of both continuous (quantitative) and threshold (qualita-for regulation of BCR signaling and sensitive to small
tive) traits and has implications for polygenic suscepti-decreases in activity. The exaggerated calcium and neg-
bility to autoimmunity, for genetic analysis of signalingative selection responses of lyn2/2 IgHEL B cells to antigen
networks in mice, and for combination drug therapy(Figures 1±3) are a phenocopy of the hyperresponse in
approaches to immune modulation.IgHEL B cells homozygous for the poorly active mev allele
of SHP-1 (Cyster and Goodnow, 1995). Likewise, the
hyperactivity in theabsence of antigen, thespontaneous Compensation for Lyn Deficiency in the Initiation
of BCR Signalingdown-regulation of surface IgM on lyn2/2 B cells, the
diminished number of recirculating mature B cells, and The BCR appears to be in an equilibrium between un-
phosphorylated and phosphorylated states that is nor-increased MHC class II, mirrors the antigen-indepen-
dent changes in mev/mev IgHEL B cells. The biochemical mally tuned by balancing BCR density, src-family and Syk
kinases, and signal-enhancing coreceptor docking sitesand genetic data in Figures 4±7 place Lyn and SHP-1
in a common pathway with Lyn kinase required to phos- (e.g., CD19/CD21) against phosphatases (e.g., SHP-1)
and inhibitory coreceptor docking sites (e.g., CD22 andphorylate the BCR coreceptor protein CD22 and recruit
SHP-1. Binding of SHP-1 via its SH2 domains to phos- FcgRIIB1). A basal level of tyrosine phosphorylation of
CD79a/b, Syk kinase, CD22, and CD19 exists in naivephorylated ITIMs of CD22 is known to activate the phos-
phatase (Doody et al., 1995), and crosslinking CD22 to IgHEL B cells in the absence of antigen (Figure 5 and data
not shown), and this is rapidly increased when antigensthe BCR can suppress extracellular signal-related pro-
tein kinase 2, c-Jun N-terminal kinase, and p38 activa- cluster and increase the local density of BCRs or when
tyrosine phosphatases are inhibited by pervanadatetion (Tooze et al., 1997). The immediate downstream
targets of SHP-1 are unresolved, but its action dimin- treatment (Wienands et al., 1996; B. T. Weintraub and
C. C. G., unpublished data). In primary Bcells, Lyn kinaseishes calcium flux as well as the mitogen-activated pro-
tein (MAP) kinases (above) and opposes responses such is not essential for the basal or antigen-induced phos-
phorylation of CD79a/b or Syk, although it appears toas the adjustment of surface IgM density and class II
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Figure 7. B Cell Hyperresponsiveness in Tri-
ple Heterozygote Mice
(A) Cell surface expression of CD21 and IgMa
on WT (shaded) and lyn1/2cd221/2mev/1 tri-
ple heterozygote (dark line) IgHEL B cells in
the bone marrow and spleen of mice lacking
sHEL self-antigen. Examples are representa-
tive of at least four mice in each group.
(B) Mean class II expression on IgHEL B cells
from mice of different genotypes lacking the
sHEL self-antigen, compared to each other
and to class II expression on anergic WT IgHEL
B cells exposed to sHEL. Dots, individual
mice.
(C) The number of HEL-binding B cells of dif-
ferent genotypes in bonemarrow, spleen,and
lymph node of mice expressingsHEL antigen.
With the exception of the nontransgenic B6/J
staining controls, the mice were radiation chi-
meras analyzed at 9±10 weeks after reconsti-
tution. Immature HEL-binding B cells were
enumerated from two femurs andtibias. Dots,
individual mice; bars, geometric means.
(D) Cell surface expression of CD21 and IgMa
on WT (shaded) and lyn1/2cd221/2mev/1 triple
heterozygote (dark line) IgHEL B cells in the
bone marrow and spleen of mice with circu-
lating sHEL self-antigen. Examples are repre-
sentative of 4 mice in each group.
assist the initial antigen-induced signaling because phos- the src kinase members would be expected to preclude
compensation amongst them.phorylation of CD79a/b or Syk was diminished, and ele-
vation of calcium occurred more slowly in HEL-stimu- The conclusion that other src kinases compensate for
Lyn in promoting certain BCR signaling pathways islated lyn2/2 IgHEL cells (Figures 3 and 5). It is likely that
the other src kinases expressed in primary B cells, such consistent with analyses of lyn2/2 DT40 chicken B cell
lymphoma cells. Lyn is the sole src kinase expressed inas Fyn and Blk, compensate for Lyn in promoting these
signaling steps because HEL-induced calcium and ex- DT40 cells, and BCR signaling is delayed and diminished
when these cells lack a functional lyn gene, much as intracellular signal-related protein kinase signaling and
negative selection responses are diminished in IgHEL B cd452/2 B cells (Kurosaki et al.,1994; Takata et al., 1994).
Transfection of lyn2/2 DT40 cells with Lck or Fyn kinasescells lacking the src-family activator CD45 (Cyster et al.,
1996). In CD45-deficient B cells, decreased activity of all restores BCR signaling and results in a delayed but
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exaggerated calcium response comparable to the lyn2/2 occurs for many other cell surface receptors. In the case
of anergic B cells, the mechanism for adjusting surfaceprimary B cells described here. In chicken DT40 cells,
Syk does appear to promote low-level BCR signaling IgM levels is achieved by inhibiting the transport of newly
assembled BCRs from the endoplasmic reticulum (Bellwithout the involvement of Lyn or other src kinases.
Src kinases cannot compensate for Syk, because BCR- and Goodnow, 1994).
Other downstream responses to BCR signaling exhib-induced calcium flux is completely abolished in syk2/2
DT40 cells (Kurosaki et al., 1994) or syk2/2 IgHEL bone ited varying sensitivities to defects in the Lyn/CD22/
SHP-1 feedback pathway. Up-regulation of class II, whichmarrow B cells (R.J.C. et al., unpublished data). Interest-
ingly, Syk does not appear to be a limiting component is normally induced by acute or chronic antigen stimula-
tion, occurs spontaneously in B cells with homozygousin BCR signaling, because syk1/2 IgHEL B cells with half
of the normal amount of this protein are not detectably mutations in lyn or SHP-1 and in the triple heterozygote
but has not been observed in B cellswhere the feedbackdifferent from WT in any of the sensitive assays de-
scribed here. pathway was crippled at only two of the three elements.
Negative selection to self-antigen by developmental ar-
rest and clonal abortion normally requires the binding
Quantitative and Qualitative Effects of Deficiency of HEL that is either a multivalent membrane array (Hart-
in the Lyn/CD22/SHP-1 Pathway ley et al., 1991) or a secreted covalent dimer (S. Akkaraju
In contrast to the initiation and propagation of BCR et al., unpublished data), implying that a higher threshold
signaling, other tyrosine kinases cannot compensate for of BCR clustering is required for this response than for
Lyn in establishing the basal or induced phosphorylation induction of anergy. Secreted HEL monomer is never-
of CD22 and recruitment of SHP-1, as these were greatly theless able to trigger clonal abortion when the feedback
reduced in lyn2/2 cells. A range of second messengers pathway is fully crippled by Lyn or SHP-1 homozygous
and responses to antigen are exaggerated or occur mutations, or to a lesser degree when the pathway is
spontaneously when the Lyn/CD22/SHP-1 feedback partially crippled in the triple heterozygous mutant. Het-
pathway is crippled to differing degrees. Calcium re- erozygous Lyn deficiency on its own also allowed this
sponses to antigen are exaggerated comparably in response to be triggered by sHEL, although the effect
lyn2/2 and mev/mev B cells, although the delay to peak was less than the triple heterozygous deficit.
calcium seen with Lyn-deficiency does not occur in Although the variation in class II expression and anti-
SHP-1 deficient cells (Cyster and Goodnow, 1995), con- body hypersecretion amongst triple heterozygote mice
sistent with a positive role for Lyn in the initial phase of could be due to genetic heterogeneity at other loci in
the calcium response. The calcium response following the backcrossed mice, it is more likely to be due to the
BCR clustering is also exaggerated in cd222/2 B cells incomplete penetrance of effects at lyn, cd22, and mev
(O'Keefe et al., 1996; Otipoby et al., 1996; Nitschke et loci. Incomplete penetrance due to age, stochastic, or
al., 1997). The antigen-induced calcium response never- environmental effects is an important feature of poly-
theless does appear to be well-buffered against partial genic disease and for any single disease-predisposing
disruption of the Lyn/CD22/SHP-1 feedback pathway, genotype is manifest as a ratio of affected and unaf-
because little exaggeration in the calcium flux could be fected individuals.
detected in single or compound heterozygous mutants
(data not shown). Compensatory processes such as the
decrease in IgM and CD21 on the partially deficient Immunoglobulin Hypersecretion and Autoimmunity
Associated with Lyn Deficiencycells (Figure 7) may provide this buffering, although they
appear insufficient to offset complete disruption of the IgM-secreting plasmacells arespontaneously produced
at a low level in the absence of HEL antigen in IgHEL-Lyn/CD22/SHP-1 pathway.
Consistent with the role of a buffer, the adjustment transgenic mice and even in homozygous Rag22/2 IgHEL
mice where no helper T cells are present. This antigen-of surface IgM density is a continuous trait that is sensi-
tive to a range of subthreshold perturbations. Thus, low independent formation of plasma cells is greatly exag-
gerated by the homozygous lyn or SHP-1 mutations andconcentrations of sHEL antigen that are below the
threshold for inducing anergy or class II up-regulation was observed in two of four triple heterozygous mice
but not in single or double heterozygous mutants. Itnevertheless cause a 50%±80% decrease in surface
IgM on mature cells that are antigen dose-dependent is conceivable that basal (antigen-independent) BCR
clustering and signaling, or occasional clustering of(Goodnow et al., 1989; Akkaraju et al., 1997). In the
absence of HEL antigen, surface IgM also decreases CD19/CD21 coreceptors by complement C3d on partic-
ular cells, normally promotes differentiation into plasmain a gene dose-dependent manner depending on the
combination of loss of function mutations in the Lyn/ cells at a low rate and that this is greatly exaggerated
by the defects in the inhibitory feedback pathway cre-CD22/SHP-1 feedback pathway (Figure 6). Overexpres-
sion of CD19, which increases BCR signaling, also ated by Lyn/CD22/SHP-1 deficiency. The greatly in-
creased plasma cell formation is reminiscent of B cellscauses a dose-dependent downward adjustment of sur-
face IgM on mature B cells (Sato et al., 1997), whereas in mice lacking the transcription factor Ets-1 (Bories et
al., 1995). BCR-induced elevation of calcium results inpartial or complete deficiency of CD45 diminishes BCR
signaling and IgM modulation to differing degrees (Cys- phosphorylation and inactivation of Ets-1 (Fisher et al.,
1991), raising the possibility that exaggerated signalingter et al., 1996). The adjustment of surface IgM density
presumably functions as a compensatory mechanism to the calcium/Ets-1 pathway in Lyn/CD22/SHP-1 defi-
ciency might account for IgM hypersecretion.to help the cell tolerate chronic stimulation, much as
Immunity
506
The hypersecretion of immunoglobulins, autoantibod- For these reasons, it will be interesting to discover if
alleles relevant to human autoimmune susceptibility ex-ies, and glomerulonephritis that occurs in lyn2/2 or
mev/mev mice with a normal BCR repertoire (Hibbs et ist within this or related regulatory pathways. Third, the
physiological significance of dosage sensitivity at eachal., 1995; Nishizumi et al., 1995; Chan et al., 1997) may
reflect a similar elevation of spontaneous plasma cell step in this signaling pathway may be that supply of
each protein can be tightly regulated by processes thatdifferentiation. Because negative selection of immature
B cells to circulating self-antigens is shown here to be activate, inhibit, or sequester these molecules, as has
been proposed for CD22. Finally, the data here indicateintact and even exaggerated, the autoantibodies se-
creted in lyn2/2 mice may arise from low-affinity autore- that it should be possible to inhibit signaling pathways
with combinations of drugs that individually reduce theactive B cells that bind self-antigens below the threshold
BCR occupancy needed to trigger negative selection. activity of different targets by small increments. This
pharmacological approach, combined with an under-Under these circumstances, autoimmune disease might
result as much from nonspecific B cell hyperactivity standing of the genetic interactions between limiting
elements in signaling pathways and the behaviour ofcausing high antibody titres and immune complexes as
from preferential production of autoantibodies. B cell common polymorphic alleles, should enable combina-
tion therapies of high specificity that correct qualitativehyperactivity with increased MHC class II expression
and hypersecretion of immunoglobulins is also a feature immune defects by quantitative adjustment.
of at least two as yet unidentified murine lupus suscepti-
bility genes, Sle3 and Sle4 (Mohan et al., 1997; Morel et
Experimental Proceduresal., 1997). These susceptibility genes interact with loci
that affect other processes leading to autoantibody pro- Mice
duction, which might include the release of antigen from C57BL/6 MD4 immunoglobulin-transgenic mice were mated with
tissues. It is possible that self-reactive B cells lacking homozygote lyn2/2 mice (Hibbs et al., 1995), heterozygote C57BL/6
mev/1 mice (Jackson Laboratory), or homozygote cd222/2 mice (Oti-Lyn could be driven further into an exaggerated plasma
poby et al., 1996). The targeted lyn allele had been incompletelycell response by the intermittent release of sequestered
backcrossed from the 129/Sv strain onto C57BL/6, and so to mini-autoantigens that they have not encountered during de-
mize the overall effect of other potentially modifying genes from the
velopment, for example, on the surface of apoptotic 129/Sv, a series of breeding pairs were established with intercross-
cells. ing lyn1/2 heterozygotes. Mice from two or more of these inter-
crosses were used in each experiment to control for any effects of
strain background. The same strategy was used for crosses with
the disrupted cd22 allele. Heterozygote immunoglobulin-transgenicPolygenic Control of Disease Susceptibility
progeny were mated with heterozygote nontransgenic partners inThe Lyn/CD22/SHP-1 negative feedback pathway illus-
a series of intercrosses. MD4 encodes an anti-HEL immunoglobulintrates that an accumulation of 2-fold differences in key
with both IgM and IgD isotypes and C57BL/6 ML5 HEL-transgenic
signaling molecules in mice creates quantitative traits mice encode soluble HEL under the metallothionien promoter at a
and qualitative changes in cell behavior. Different com- concentration of 1 nM in serum (Goodnow et al., 1988) (Induced
binations of lyn, cd22, and SHP-1 mev alleles generate Mutant Repository, Jackson Laboratory). The mice were genotyped
using a series of polymerase chain reaction assays that are availablea spectrum of BCR signaling that is reflected in quantita-
on request.tive compensatory IgM modulation. When the cumula-
tive genetic defects in the Lyn/CD22/SHP-1 pathway
exceed a certain threshold, as in the triple heterozygous Radiation Chimeras, Flow Cytometry,
and Antibody Measurementsmutant mice, overt B cell hyperactivity occurs. This gene
Radiation chimeras were reconstituted as previously describeddosage sensitivity has several implications. First, it indi-
(Cyster and Goodnow, 1995). As far as possible, chimeras of differ-cates that the powerful genetic enhancer/suppressor
ent genotype were analyzed as complete cohorts, and no differ-
approaches used to understand signaling networks in ences were observed between mice that had been reconstituted
Drosophila or C. elegans (Simon et al., 1991; Yoon et for different periods, which were not less than 7 or greater than 17
al., 1995; Verheyen et al., 1996) should also be feasible weeks.
A three-color fluorescence-activated cell sorter (FACS) analysisin mice. Second, cumulative effects of multiple weak
was performed on a FACScan with FACS desk software (Beckmanalleles in the manner described here may characterise
Center Shared FACS facility). Surface marker staining and calciumgenetic predisposition to many complex diseases such
analysis was performed as previously described (Goodnow et al.,
as autoimmune diabetes and systemic lupus erythema- 1988; Mason et al., 1992; Hartley et al., 1993; Cyster and Goodnow,
tosus. In these diseases, multiple loci contribute to the 1995; Cyster et al., 1996).
relative risk of disease, and locus heterogeneity exists Serum anti-HEL IgMa and IgDa was measured by enzyme-linked
immunosorbent assay as previously described (Cyster and Good-such that different combination of alleles can have
now, 1995), and anti-HEL IgMa±secreting cells were enumerated inequivalent effects on the risk of disease (Morel et al.,
spleen by spot enzyme-linked immunosorbent assay as described1994; Drake et al., 1995; Theofilopoulos, 1995b; Vyse
(Rathmell and Goodnow, 1994).
and Todd, 1996; Morel et al., 1997). It is interesting that
one of the intervals associated with B cell hyperactivity
Cell Lysates and Western Blot Analysisand autoimmune glomerulonephritis in the NZB/W mouse
Splenocytes for stimulation were isolated at room temperature,model of systemic lupus, Sle3, contains the CD22 locus
washed, and resuspended in 5% fetal calf serum, RPMI, and 10 mM(Morel et al., 1997). Because lyn, cd22, and SHP-1 en-
HEPES. Prior to stimulation, both cells and stimulant were pre-
code limiting steps in the B cell response to antigen, warmed for 5 min at 378C, and reactions were initiated by combining
any genetic variants arising at these loci could generate them in a ratio of 3:1, which gave instant mixing. Stimuli were media
alone for the full time course in the case of all unstimulated samples,a powerful mechanism for their own natural selection.
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HEL (final concentration in media 1 mg/ml), and polyclonal goat anti- Anti-immunoglobulin stimulation of B lymphocytes activates src-
related protein-tyrosine kinases. Proc. Natl. Acad. Sci. USA 88,mouse IgM (final concentration 10 mg/ml; Jackson Immunochemi-
7410±7414.cals). Reactions were terminated by transferring cells into an equal
volume of ice-cold 23 Nonidet P-40 (NP-40) lysis buffer (composi- Campbell, M.A., and Sefton, B.M. (1992). Association between
tion of 1X NP-40 lysis buffer: 1% NP-40, 50 mM Tris [pH 8.0], 150 B-lymphocyte membrane immunoglobulin and multiple members
mM sodium chloride, 5 mM EDTA, 20 mM sodium fluoride, 20 mM of the src family of protein tyrosine kinases. Mol. Cell. Biol. 12,
b-glycerol phosphate, 5 mM iodoacetamide, 1 mM NaVO4, 2.5 mM 2315±2321.
PMSF, and 40 mg/ml each aprotinin and leupeptin). After 15 min on Campbell, M.A., and Klinman, N.R. (1995). Phosphotyrosine-depen-
ice, the samples were centrifuged at 14,000 3 g and 48C for 15 min dent association between CD22 and the protein tyrosine phospha-
and the supernatants transferred to ice-cold streptavidin±agarose tase 1C. Eur. J. Immunol. 25, 1573±1579.
(Gibco-BRL) that had been preblocked with 1% bovine serum albu-
Chan, V.W.F., Meng, F., Soriano, P., DeFranco, A.L., and Lowell,min and washed in 13 lysis buffer. After 15 min incubation with
C.A. (1997). Characterization of the B lymphocyte populations ingentle rotation, the samples were centrifuged and the supernatant
Lyn-deficient mice and the role of Lyn in signal initiation and down-
transferred to anti-CD22-biotin (Pharmingen) that had been pre-
regulation. Immunity 7, 69±81.
bound in the presence of 1% bovine serum albumin to strepavidin±
Cyster, J.G., and Goodnow, C.C. (1995). Protein tyrosine phospha-agarose (Gibco-BRL) and washed several times in 13 NP-40 lysis
tase 1C negatively regulates antigen receptor signaling in B lympho-buffer. Prebinding the anti-CD22 biotin to the agarose was critical
cytes and determines thresholds for negative selection. Immunityto the yield of CD22 in immunprecipitation. Immunoprecipitation of
2, 13±24.CD22 from the lysates proceeded with gentle rotation of the samples
Cyster, J.G., and Goodnow, C.C. (1997). Tuning antigen receptorfor 1 hr in the cold. Agarose samples were then washed three times
signaling by CD22: integrating cues from antigens and the microen-in ice-cold 13 NP-40 lysis buffer (without inhibitors) with gentle
vironment. Immunity 6, 509±517.centrifugation and careful fine-needle aspiration of supernatants.
Finally, agarose pellets were suspended in SDS±polyacrylamide gel Cyster, J.G., Healy, J.I., Kishihara, K., Mak, T.W., Thomas, M.L.,
electrophoresis sample buffer and boiled for 5 min. Serial immuno- and Goodnow, C.C. (1996). CD45 sets thresholds for negative and
precipitations of first IgB and then Syk followed that of CD22 using positive selection of B lymphocytes. Nature 381, 325±328.
rabbit polyclonal antisera to IgB (prepared by JGC) and Syk (a gift DeFranco, A.L. (1997). The complexity of signaling pathways acti-
from A. DeFranco). At each cycle, the residual supernatant was vated by the BCR. Curr. Opin. Immunol. 9, 296±308.
preincubated with protein G± or protein A±agarose (Gibco-BRL),
Doody, G.M., Justement, L.B., Delibrias, C.C., Matthews, R.J., Lin,
incubated with anti-serum for 1±3 hr, and then added once again J., Thomas, M.L., and Fearon, D.T. (1995). A role in B cell activation
to protein G± or protein A±agarose for 1 hr with mixing and finally for CD22 and the protein tyrosine phosphatase SHP. Science 269,
the agarose pellet washed and resuspended in SDS±polyacrylamide 242±244.
gel electrophoresis sample buffer. Great care was taken not to cross
Drake, C.G., Rozzo, S.J., Vyse, T.J., Palmer, E., and Kotzin, B.L.contaminate samples and all steps were performed at 48C. Immuno-
(1995). Genetic contributions to lupus-like disease in (NZBxNZW)F1precipitated samples were resolved on 8%±12% SDS±polyacryl-
mice. Immunol. Rev. 144, 51±74.amide gel electrophoresis and immunoblotted with antiphosphoty-
Fisher, C.L., Ghysdael, J., and Cambier, J.C. (1991). Ligation ofrosine (Mab 4G10, Upstate Biotechnology) and anti-SHP-1 (a gift
membrane Ig leads to calcium-mediated phosphorylation of thefrom M. Thomas), and rabbit polyclonal anti-CD22 (a gift from P.
proto-oncogene product, Ets-1. J. Immunol. 146, 1743±1749.Crocker), anti-Igb, and anti-Syk. Detection was by enhanced chemi-
luminescence (Amersham). Goodnow, C.C. (1996). Balancing immunity and tolerance: deleting
and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA 93,
2264±2271.Acknowledgments
Goodnow, C.C., Crosbie, J., Adelstein, S., Lavoie, T.B., Smith-Gill,
S.J., Brink, R.A., Pritchard-Briscoe, H., Wotherspoon, J.S., Loblay,The authors wish to thank the following for helpful comments and
R.H., Raphael, K., et al. (1988). Altered immunoglobulin expressionadvice: S. Akkaraju, J. I. Bell, R. Clark, S. J. Davis, H. Ferry, R. J.
and functional silencing of self-reactive B lymphocytes in transgenicGlynne, J. I. Healy, S. Pogue, J. C. Rathmell, J. A. Todd, S. E.
mice. Nature 334, 676±682.Townsend, and B. T. Weintraub. R. J. C. is supported by a Wellcome
Goodnow, C.C., Crosbie, J., Jorgensen, H., Brink, R.A., and Basten,Trust Career Development Award; J. G. C. is a Pew scholar; M. L. H.
A. (1989). Induction of self-tolerance in mature peripheral B lympho-is supported by a Senior Research Fellowship from the Australian
cytes. Nature 342, 385±391.Research Council; K. L. O is supported by a Howard Hughes Medical
InstitutePredoctoral Fellowship; E. A. C. is supported by the National Hartley, S.B., Crosbie, J., Brink, R., Kantor, A.A., Basten, A., and
Goodnow, C.C. (1991). Elimination from peripheral lymphoid tissuesInstitutes of Health Grant GM 42508; and C. C. G. was an Investigator
of self-reactive B lymphocytes recognizing membrane-bound anti-of the Howard Hughes Medical Institute.
gens. Nature 353, 765±768.
Hartley, S.B., Cooke, M.P., Fulcher, D.A., Harris, A.W., Cory, S.,Received December 19, 1997; revised February 13, 1998.
Basten, A., and Goodnow, C.C. (1993). Elimination of self-reactive
B lymphocytes proceeds in two stages: arrested development and
References cell death. Cell 72, 325±335.
Hibbs, M.L., Tarlinton, D.M., Armes, J., Grail, D., Hodgson, G., Mag-
Akkaraju, S., Canaan, K., and Goodnow, C.C. (1997). Self-reactive litto, R., Stacker, S.A., and Dunn, A.R. (1995). Multiple defects in the
B cells are neither eliminated nor inactivated by autoantigen ex- immune system of lyn-deficient mice, culminating in autoimmune
pressed on thyroid epithelial cells. J. Exp. Med. 186, 2005±2012. disease. Cell 83, 301±311.
Bell, S.E., and Goodnow, C.C. (1994). A selective defect in IgM Kurosaki, T. (1997). Molecular mechanisms in B cell antigen receptor
antigen receptor synthesis and transport causes loss of cell surface signaling. Curr. Opin. Immunol. 9, 309±318.
IgM expression on tolerant B lymphocytes. EMBO J. 13, 816±826. Kurosaki, T., Takata, M., Yamanashi, Y., Inazu, T., Taniguchi, T.,
Bolen, J.B., and Brugge, J.S. (1997). Leukocyte protein tyrosine Yamamoto, T., and Yamamura, H. (1994). Syk activation by the src-
kinases: potential targets for drug discovery. Annu. Rev. Immunol. family tyrosine kinase in the B cell receptor signaling. J. Exp. Med.
15, 371±404. 179, 1725±1729.
Bories, J.-C., Willerford, D.M., GreÂ vin, D., Davidson, L., Camus, A., Law, C.-L., Sidorenko, S.P., Chandran, K.A., Zhao, Z., Shen, S.-H.,
Martin, P., SteÂhelin, D., and Alt,F.W. (1995). Increased T-cell apopto- Fischer, E.H., and Clark, E.A. (1996). CD22 associates with protein
sis and terminal B-cell differentiation induced by inactivation of the tyrosine phosphatase 1C, Syk, and phospholipase C-g1 upon B cell
Ets-1 proto-oncogene. Nature 377, 635±638. activation. J. Exp. Med. 183, 547±560.
Leprince, C., Draves, K.E., Geahlen, R.L., Ledbetter, J.A., and Clark,Burkhardt, A.L., Brunswick, M., Bolen, J.B., and Mond, J.J. (1991).
Immunity
508
E.A. (1993). CD22 associates with the human surface IgM±B-cell Wienands, J., Larbolette, O., and Reth, M. (1996). Evidence for a
preformed transducer complex organized by the B cell antigen re-antigen receptor complex.Proc. Natl. Acad. Sci. USA 90,3236±3240.
ceptor. Proc. Natl. Acad. Sci. USA 93, 7865±7870.Mason, D.Y., Jones, M., and Goodnow, C.C. (1992). Development
and follicular localization of tolerant lymphocytes in lysozyme/anti- Yamanashi, Y., Kakiuchi, T., Mizuguchi, J., Yamamoto, T., and Toy-
oshima, K. (1991). Association of B cell antigen receptor with proteinlysozyme IgM/IgD transgenic mice. Int. Immunol. 4, 163±175.
tyrosine kinase Lyn. Science 251, 192±194.Mohan, C., Morel, L., Yang, P., and Wakeland, E.K. (1997). Genetic
dissection of systemic lupus erythematosus pathogenesis. J. Immu- Yoon, C.H., Lee, J., Jongeward, G.D., and Sternberg, P.W. (1995).
Similarity of sli-1, a regulator of vulval development in C. elegans,nol. 159, 454±465.
to the mammalian proto-oncogene c-cbl. Science 269, 1102±1105.Morel, L., Rudofsky, U.H., Longmate, J.A., Schiffenbauer, J., and
Wakeland, E.K. (1994). Polygenic control of susceptibility to murine
systemic lupus erythematosus. Immunity 1, 219±229.
Morel, L., Mohan, C., Ying, Y., Croker, B.P., Tian, N., Deng, A.,
and Wakeland, E.K. (1997). Functional dissection of systemic lupus
erythematosus using congenic mouse strains. J. Immunol. 158,
6019±6028.
Nishizumi, H., Taniuchi, I., Yamanashi, Y., Kitamura, D., Ilic, D., Mori,
S., Watanabe, T., and Yamamoto, T. (1995). Impaired proliferation
of peripheral B cells and indication of autoimmune disease in lyn-
deficient mice. Immunity 3, 549±560.
Nitschke, L., Carsetti, R., Ocker, B., Kohler, G., and Lamers, M.C.
(1997). CD22 is a negative regulator of B cell receptor signaling.
Curr. Biol. 7, 133±143.
O'Keefe, T.L., Williams, G.T., Davies, S.L., and Neuberger, M.S.
(1996). Hyperresponsive B cells in CD22-deficient mice. Science
274, 798±801.
Otipoby, K.L., Andersson, K.B., Draves, K.E., Klaus, S.J., Garr, A.G.,
Kerner, J.D., Perlmutter, R.M., Law, C.-L., and Clark, E.A. (1996).
CD22 regulates thymus independent responses and the lifespan of
B cells. Nature 384, 634±637.
Peaker, C.J., and Neuberger, M.S. (1993). Association of CD22 with
the B cell antigen receptor. Eur. J. Immunol. 23, 1358±1363.
Rathmell, J.C.,and Goodnow, C.C. (1994). Effects of the lpr mutation
on elimination and inactivation of self-reactive B cells. J. Immunol.
153, 2831±2842.
Sato, S., Miller, A.S., Inaoki, M., Bock, C.B., Jansen, P.J., Tang, M.L.,
and Tedder, T.F. (1996). CD22 is both a positive and a negative
regulator of B lymphocyte antigen receptor signal transduction: al-
tered signaling in CD22-deficient mice. Immunity 5, 551±562.
Sato, S., Steeber, D.A., Jansen, P.J., and Tedder, T.F. (1997). CD19
expression levels regulate B lymphocyte development: human CD19
restores normal function in mice lacking endogenous CD19. J. Im-
munol. 158, 4662±4669.
Simon, M.A., Bowtell, D.D.L., Dodson, G.S., Laverty, T.R., and Rubin,
G.M. (1991) Ras and a putative guanine nucleotide exchange factor
perform crucial steps in signaling by the sevenless protein tyrosine
kinase. Cell 67, 701±716.
Takata, M., Sabe, H., Hata, A., Inazu, T., Homma, Y., Nukada, T.,
Yamamura, H., and Kurosaki, T. (1994). Tyrosine kinases Lyn and
Syk regulate the B cell receptor-coupled Ca21 mobilization through
distinct pathways. EMBO J. 13, 1341±1349.
Theofilopoulos, A.N. (1995a). The basis of autoimmunity: Part I.
Mechanisms of aberrant self-recognition. Immunol. Today 16, 90±98.
Theofilopoulos, A.N. (1995b). The basis of autoimmunity: Part II.
Genetic predisposition. Immunol. Today 16, 150±159.
Tooze, R.M., Doody, G.M., and Fearon, D.T. (1997). Counterregula-
tion by the coreceptors CD19 and CD22 of MAP kinase activation
by membrane immunoglobulin. Immunity 7, 59±67.
Tuscano, J., Engel, P., Tedder, T.F., Agarwal, A., and Kehrl, J.H.
(1996). Involvement of p72syk kinase, p53/56lyn kinase and phos-
phatidylinositol-3 kinase in signal transduction via the human B
lymphocyte antigen CD22. Eur. J. Immunol. 26, 1246±1252.
Verheyen, E.M., Purcell, K.J., Fortinin, M.E., and Artavanis-Tsako-
nas, S. (1996). Analysis of dominant enhancers and suppressors of
activated Notch in Drosophila. Genetics 144, 1127±1141.
Vyse, T.J., and Todd, J.A. (1996). Genetic analysis of autoimmune
disease. Cell 85, 311±318.
Wang, J., Koizumi, T., and Watanabe, T. (1996). Altered antigen
receptor signaling and impaired Fas-mediated apoptosis of B cells
in Lyn-deficient mice. J. Exp. Med. 184, 831±838.
